Vir Biotechnology Appoints Mark Eisner As EVP And Chief Medical Officer

RTTNews | 454 dagar sedan
Vir Biotechnology Appoints Mark Eisner As EVP And Chief Medical Officer

(RTTNews) - Immunology company Vir Biotechnology, Inc. (VIR) announced Wednesday that Mark Eisner will join the company as Executive Vice President and Chief Medical Officer (CMO), effective June 03, 2024.

Eisner will be a part of the company's Executive Management Team and will report directly to Chief Executive Officer Marianne De Backer.

Eisner brings to Vir deep immunology and infectious disease expertise with clinical development experience. He has an impressive track record of leading teams during times of strategically evolving portfolios.

Eisner comes from Sonoma Biotherapeutics, where he most recently held the position of CMO. Prior to his most recent tenure with Sonoma, Eisner served as CMO at FibroGen where he led all development functions, which included being the Head of China clinical development and clinical operations.

Eisner has also been with Genentech nearly 11 years and served as their Senior Vice President of Global Head of Product Development Immunology, Infectious Disease and Ophthalmology.

read more
Bay Street May Open On Weak Note

Bay Street May Open On Weak Note

Canadian shares look headed for negative start on Tuesday, weighed down by weak oil prices, and concerns about global trade after U.S. President Donald Trump threatened 200% tariffs on China if Beijing does not export rare-earth magnets to the U.S.
RTTNews | 1h 18minuter sedan
U.S. Durable Goods Orders Tumble Less Than Expected In July

U.S. Durable Goods Orders Tumble Less Than Expected In July

Reflecting a continued plunge by orders for transportation equipment, the Commerce Department released a report on Tuesday showing a steep drop by new orders for U.S. manufactured durable goods in the month of July.
RTTNews | 1h 24minuter sedan
FTSE 100 Modestly Lower

FTSE 100 Modestly Lower

After posting gains in the previous five sessions, the U.K. market is exhibiting weakness on Tuesday, weighed down by losses in financials and retail sectors.
RTTNews | 1h 46minuter sedan
CAC Down Sharply On Widespread Selling

CAC Down Sharply On Widespread Selling

French stocks are down sharply on Tuesday, extending previous session's steep drop, amid ongoing political uncertainty in the country.
RTTNews | 2h 11minuter sedan
DAX Extending Recent Weakness

DAX Extending Recent Weakness

German stocks are down in negative territory on Tuesday, extending losses from the previous session, due to geopolitical concerns and uncertainty about tariffs.
RTTNews | 3h 34minuter sedan
Sensex, Nifty Tumble On Tariff Worries

Sensex, Nifty Tumble On Tariff Worries

Indian shares tumbled on Tuesday after the Trump administration officially issued a notice regarding the imposition of an additional 25 percent tariffs on Indian imports, with the punitive duties set to kick in at 12:01 am (EST) on August 27.
RTTNews | 3h 38minuter sedan
French Consumer Sentiment Weakest Since 2023

French Consumer Sentiment Weakest Since 2023

France's consumer confidence weakened to the lowest level since October 2023 largely due to the weaker outlook for standard of living and the fall in saving intentions. The consumer sentiment index edged down to 87 in August from 88 in July. This was the lowest reading since October 2023 and remained below its long-term average of 100.
RTTNews | 4h 47minuter sedan